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Abstract 
This  study  aimed  to  assess  the  feasibility
and  results  of  hyperbaric  oxygen  therapy
(HOT)  as  supportive  treatment  of  lesions  of
superficial soft tissues in children with onco-
logical diseases. This was a retrospective analy-
sis  and  review  of  all  records  of  children
observed at the Pediatric Hematology-Oncology
Department  of  the  University  of  Padova  and
treated adjuvantly with HOT. Between 1996 and
2010, 12 patients (5 males and 7 females, medi-
an age 7 years, range 0.5-16) underwent HOT.
The effectiveness of HOT varied according to
the lesion treated. Ten out of 12 patients were
cured.  Efficacy  was  most  questionable  in  2
patients  with  skin  graft  and  flaps  at  risk.
Compliance to therapy was close to 100%. In
just  one  case,  HOT  was  interrupted  for  the
appearance of local skin metastases close to
the site of primary tumor. HOT showed itself to
be  safe  and  effective  in  most  patients  even
those immunocompromised or critically ill. 
Introduction
There are large variations in clinical opin-
ion and practice concerning local and systemic
treatment of skin and soft tissue lesions, and a
wide range of therapeutic strategies are adopt-
ed. Among these, HOT is widely recommended
in adults on the basis of scientific evidence or
well-established clinical experience.1,2 HOT is
a bloodless treatment implemented by breath-
ing pure oxygen (O2) in hyperbaric chambers,
where air pressures are greater than those of
the  ground  atmosphere  (1  atmosphere
absolute, ATA). Therapeutic action depends on
the increased amount of O2 that is conveyed to
the tissues dissolved in plasma. Since O2 in
high doses is toxic to normally perfused tis-
sues, particularly brain and lungs, HOT should
not continue for longer than 1-2 h.1
There  are  few  data  concerning  the  treat-
ment of complicated lesions of skin and super-
ficial  soft  tissue  with  HOT  therapy  in  chil-
dren.3-11 To date, standard regimens, used for
adults for the treatment of various diseases,
are not available in children and it is fairly
obvious that every child requires an individual-
ized treatment. Therefore, the application of
HOT therapy in this age group requires, beside
the knowledge of the basic principles that reg-
ulate HOT, also a close collaboration between
the different specialists involved in the care of
the  child.  Moreover,  adaptation  of  medical
instruments and O2 delivery systems according
to patient age is required.9,10
The aim of the study was to assess the fea-
sibility and results of HOT therapy as support-
ive treatment of diseases of skin and superfi-
cial soft tissues in a particular group of chil-
dren with oncological diseases. 
Materials and Methods 
Between January 1996 and December 2010,
31  consecutive  children  were  treated  in  the
Department  of  Pediatrics  of  the  University
Hospital of Padova with adjuvant HOT therapy
for skin and soft tissue lesions. The records of
12 of 31 patients treated for oncological disor-
ders were reviewed. Patients were 5 males and
7 females, age ranged from 6 months to 16
years (median 7 years). 
Preparation of the pediatric patient to HOT
therapy  required:  i)  informing  parents  and
adolescents  on  how  HOT  is  performed;  ii)
teaching the patient how to equilibrate middle
ear pressure by swallowing, yawning, chewing,
or  sucking  a  pacifier;  iii)  use  of  bilateral
myringotomy in smaller children; iv) chest X-
ray to rule out underlying diseases predispos-
ing  to  tension  pneumothorax  and  barotrau-
mas,  such  as  pulmonary  cysts,  emphysema,
asthma.  In  addition,  heart  function  was
checked with ECG. 
HOT  was  administered  in  a  multi-person
hyperbaric  chamber.  Patients  entered  the
chamber  with  the  physician  and  sometimes
with a family member. In hyperbaric chambers
O2 has  to  be  inhaled  through  an  uncuffed
endotracheal tube, a cushioned face mask or a
head  helmet.  The  O2 delivery  system  was
adapted  to  the  age  and  condition  of  the
patient.9 In particular, since it is impossible to
apply a facial-mask in patients under the age
of one year, the smallest children were intro-
duced from the belly to the head into a classic
adult head helmet [Figure 1]. Standard treat-
ment protocol included HOT at a pressure of
2.0 up to 2.5 ATA (in adults 3 ATA are normally
used).9 Patients breathed pure O2 for three 25-
min  periods,  interrupted  by  two  5-min  air
breaks to avoid O2 cerebral toxicity. Treatment
was  normally  administered  once  daily  for  5
days each week, with a schedule of up to a
maximum of 60 sessions.1,9 The precise thera-
peutic schema was not the same for all chil-
dren, but was tailored according to their dis-
ease and continued on the basis of the results
achieved. For each patient, demographic and
disease-related data, such as sex, age, underly-
ing disease, indication to HOT, number of ses-
sions, duration and pressures of HBO, effects
and outcome after this supportive therapy, side
effects and degree of compliance to therapy,
were collected. After HOT all patients were fol-
lowed  for  a  median  duration  of  five  years
(range  1-10  years).  This  retrospective  study
was  approved  by  the  ethics  committee  at
Padova University Hospital. 
Results
The 12 patients were divided into 6 groups
according to indication for HOT therapy. Their
clinical features, schema and results of treat-
ment are summarized in Table 1.
Group 1 included one male (patient n. 1.1)
affected  by  necrotising  fasciitis  (NF)  of  the
buttock-perineal  region  and  one  female
(patient n. 1.2) with gas gangrene (GG) of the
head/neck region (Figure 2A). In both cases,
neutropenia was seen at the time of presenta-
tion of infection. The underlying malignancies
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were  acute  lymphoblastic  leukemia  (ALL)
(patient n. 1.1) and neuroblastoma (patient n.
1.2). The diagnosis of GG was made on the
basis of history, fever, tachycardia, severe pain,
septic  shock,  appearance  of  head  and  neck
superficial tissue, odor, crepitation of tissue,
and presence of gas in X-ray. The finding of
Gram-positive rods in a Gram stain confirmed
the diagnosis. The child required placement of
multiple  decompressive  drains  and  fas-
ciotomies, and was then transferred into the
hyperbaric  room,  intubated  and  ventilated
(Figure 2B). After 36 h of HOT and respiratory
stabilization (Figure 2C), a surgical debride-
ment with large removal of the infected and
dead tissue was performed. 
Group 2 included 2 infants with a perineal
abscess associated to immunodeficiency sec-
ondary  to  chemotherapy  for  ALL  and  acute
myeloid leukemia (AML), respectively. In both
patients, incision and drainage of the abscess
were carried out and the temporary colostomy
was performed to protect the area before HOT
to avoid the passage of stool through the anus
and contamination of the perianal wounds. 
Group 3 included 2 teenagers treated with
HOT therapy for poor healing surgical wounds;
both patients had recently undergone a thora-
cotomy for resection of pulmonary aspergillo-
ma (patient n. 3.1) and a laparotomy due to
intussusception (patient n. 3.2). At the time of
surgery, both patients were immunodepressed.
Wounds underwent repeated surgical debride-
ment during HOT therapy, and subsequently
healed. 
Group 4 consisted of 2 children (patient n.
4.1 and patient n. 4.2), who underwent HOT
therapy  for  skin  ulcers  due  to  arterial  or
venous  insufficiency.  Both  patients  had
received  chemotherapy  for  ALL.  Skin  ulcers
took a very long time to heal. They were kept
clear of dead tissue through repeated surgical
cleaning. Topical antibiotics were used to pre-
vent the ulcer becoming infected.
Group 5 included 2 children treated for post-
actinic  injuries.  Both  patients  had  received
brachytherapy  after  resection  of  soft  tissue
sarcoma  (STS)  of  the  forearm.  During  HOT
therapy, they required a combined treatment
consisting of surgical debridement and antibi-
otic therapy. 
Group  6  included  2  adolescents  with  skin
grafts and skin flaps at risk. Both had under-
gone excision of a large mass located on the
limbs (respectively PNET-Ewing sarcoma and
STS), with extensive loss of tissue and place-
ment of a skin flap. Patient n. 6.2 discontinued
HOT after 8 sessions because of the appear-
ance  of  a  metastatic  skin  nodule.  No  skin
flap/graft was preserved despite early start of
HOT, and a new surgical intervention was nec-
essary.
Discussion
The efficacy of HOT therapy for skin and
superficial  soft  tissue  lesions  is  well  docu-
mented in adults; however, there are very few
data concerning the pediatric population with
oncological  diseases.  Most  scientific  studies
on  children  with  oncological  disease  who
underwent HOT therapy concern hemorrhagic
cystitis,12 brain  abscesses13 and  aseptic
osteonecrosis.14 In 1996, Asharnalla HL et al.7
described one 10-year old child who underwent
radiation therapy for cancer who had a radio-
induced superficial soft tissue lesion, other-
wise successfully treated with HOT therapy. In
2001, Johnston et al.10 presented 7 cases of NF
associated  with  chemotherapy-induced  neu-
tropenia  treated  with  broad-spectrum  intra-
venous  antibiotics,  urgent  surgical  interven-
tion and HOT therapy. In 2002, Fustes-Morales
et al.11 reported 39 children with NF treated
with HOT as adjuvant therapy. Just 3 of 39 had
ALL as underlying factor. In 2006, Smith-Slatas
et al.8 reviewed all reported pediatric cases in
the  English  language  literature  with
Clostridium  septicum  infection  treated  with
HBO therapy as supportive therapy. They iden-
tified a total of 47 cases of Clostridium sep-
ticum infection and malignancies were found
in 49% of the cases, with AML and ALL as the
most common diagnoses. 
In our series, the adult treatment regimens
were successfully applied by simply decreasing
the O2 pressure and tailoring the frequency of
the sessions.1-4 In agreement with the interna-
tional  guidelines  on  HOT  therapy,  most
patients  started  treatment  as  soon  as  they
could, but the 2 children (patient ns. 1.1 and
1.2)  who  had  a  slight  delay  also  obtained  a
good result. Concerning the O2 delivery sys-
tem, we reported the successful use of the clas-
sic head helmet in infants. The number of HBT
sessions varied and was very different also for
the same disease, whereas its effectiveness,
clinically evaluated during and at the end of
treatment, appeared to be dependent on the
disease. The effectiveness of HOT therapy was
questionable in patients with skin graft and
flaps at risk. Unfortunately, in both our cases
(patients n. 6.1 and 6.2), HOT therapy started
long after the first signs of cyanosis or reject
and no pre-operative HOT therapy was carried
out, as suggested by the international guide-
lines.7 Moreover, in one of these 2 patients,
therapy was interrupted for the appearance of
local skin metastases close to the site of pri-
mary  tumor.  It  is  questionable  whether  the
HOT therapy could have favored their appeare-
ance. However, there is no clear evidence that
there is a link between HOT and the appear-
ance of metastases. In vitro, in vivo and clini-
cal studies strongly suggest that HOT therapy
has  no  influence  on  tumor  growth.15 This
treatment  increases  tumor  oxygenation  and
may, therefore, improve the radiation response
of many solid tumors during radiotherapy, and
also increase sensitivity to chemotherapy and
photodynamic therapy.16
In our series, HOT therapy was well tolerat-
ed  and  compliance  was  close  to  100%.
Tolerance was improved by having physicians
and  sometimes  family  members  accompany
the  children  during  all  their  treatment.  The
outcome  in  our  series  was  excellent.  All
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Figure 1. A child introduced from the belly
to the head into a classic adult head hel-
met.
Figure 2. Hyperbaric oxygen treatment: A)
a child with gas gangrene of the head/neck
region;  B)  a  child  into  the  hyperbaric
room (intubated and ventilated); C) respi-
ratory stabilization.[Pediatric Reports 2012; 4:e1] [page 3]
patients except 2 (83%) responded very well.
Comparable  outcome  was  also  reported  in
other pediatric retrospective analysis.7,9 In the
study  of  Asharnalla  et  al.,  90%  of  pediatric
patients  were  successfully  treated  while
Waisman  et  al., report  93%  of  pediatric
patients were successfully treated. 
It is difficult to draw conclusions from these
retrospective data concerning a small series of
patients with different diseases. In our experi-
ence, only patients with more severe complica-
tions underwent this therapy. The main limita-
tion regards the evaluation of HBO effective-
ness which was based only on the judgement
of the physician during and at the end of the
treatment.  Moreover,  it  is  difficult  to  assess
the role of HBO in the whole treatment. 
This study showed that HBO is a safe and
effective  supportive  treatment  if  considered
promptly for complex skin and superficial soft
tissues pathologies involving multiple risk fac-
tors, such as those reducing the activation or
efficacy of the immune system. It can reduce
the need for further surgery and improve out-
come after the occurrence of complications. 
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